Rothschild Investment LLC’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Rothschild Investment LLC’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10	Closed	-$157	–	2854
2024 Q1	$157	Buy	+10	New	+$154	﹤0.01%	1879

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rothschild Investment LLC's DCPH Position: Q2 2024 in Review

Rothschild Investment LLC sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 10 shares — an estimated $157 sold.

Rothschild Investment LLC first reported a position in DCPH in Q1 2024 and held it in 1 quarter. The position peaked at $157 in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Rothschild Investment LLC reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Rothschild Investment LLC sold 10 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $157.
Rothschild Investment LLC first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Rothschild Investment LLC's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $157 in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Rothschild Investment LLC's 13F filing for Q2 2024, filed 31 Jul 2024.